Tag Archives: biotech valuations

Cash Rich, Valuation Poor: Current State Of This Biotech IPO Vintage
February 5, 2016

The equity markets have softened tremendously in recent weeks and the NASDAQ Biotech Index has swooned to levels last held in late 2014, in line with other equity indices like the S&P500.  Triggered by significant and negative macro forces, this

1 Comment